The tumour necrosis factor-a (TNF-a) promoter À308 A/G polymorphism plays an important role in the aetiology of systemic lupus erythematosus (SLE). Several studies have estimated the association between TNF-a À308 A/G and SLE risk. However, results were inconsistent. A case-control study was carried out to explore the association between TNF-a À308 A/G and the SLE risk in a Chinese Han population. Meta-analysis combining present with previous studies was conducted to further explore the association. Our case-control study included 556 patients with SLE along with 570 matched healthy controls. TNF-a À308 A allele was significantly increased in patients with SLE compared with controls (OR = 2.184, 95% CI: 1.718-2.778, P < 0.001). Genotypes AA and AG were associated with the susceptibility to SLE as compared with the GG genotype, as well as the dominant model (AA+AG versus GG), respectively. The metaanalysis included 41 comparative studies involving 4799 patients and 6635 controls. An association between SLE and allele A was found in the overall populations (OR = 1.70, 95% CI: 1.46-1.98, P < 0.001). In addition, we discussed the correlation between this polymorphism and lupus nephritis (LN) risk, showing that allele A was significantly related to LN in the overall populations (OR = 1.80, 95% CI: 1.21-2.68, P = 0.004). The results from our case-control study and the meta-analysis indicate that the TNF-a À308 A allele is significantly associated with an increased risk of SLE/LN.
Introduction
Systemic lupus erythematosus (SLE) is a multisystem chronic autoimmune disease attributed to the biosynthesis of numerous autoantibodies and formation and deposition of immune complexes, resulting in inflammation and tissue damage in various organs. Lupus nephritis (LN) is the dominant cause of morbidity and mortality in SLE. While the aetiology of SLE remains unclear, data from available evidence have demonstrated an underlying genetic basis; for instance, twin and family studies provide evidence that a genetic component contributes to disease susceptibility [1] . Among the genetic factors believed to affect susceptibility to SLE, the major histocompatibility complex (MHC) alleles show the most significant association. However, studies have shown that non-HLA genes may play an important role in the pathogenesis of SLE.
Tumour necrosis factor-alpha (TNF-a) is a potential proinflammatory cytokine that strongly contributes to inflammatory and immune responses by inducing a cascade of various inflammatory cytokines, chemokines. It is produced as a trimer on the surface of cells, the soluble form of which is released after the activation of macrophages and dendritic cells. Previous investigation showed that serum levels of TNF-a were increased in patients with SLE when compared to healthy controls, and higher TNF-a levels in patients with SLE correlated with active disease [2] . In addition, the TNF-a is highly expressed in both serum and renal tissue of MRL/lpr mice [3] . The TNF-a gene is located on chromosome 6p21.3, within the class III region of MHC. A change G-to-A single-nucleotide polymorphism (SNP) at position À308 directly affects gene regulation and has been associated with altered transcriptional activity of TNF-a in various disorders [4, 5] . In fact, this SNP is functionally relevant, and the TNF-a À308 A allele correlates with higher transcriptional activity [6] . Interestingly, the A allele has been found associated with the risk of SLE in several studies; however, some other studies reported inconsistent results. For example, Ahmed et al. [7] found that frequency of TNF-a À308 genotype AA was strongly increased in Egypt patients with SLE (26%) compared to the frequency in the control group (10%), and the frequency of the A allele was significantly higher in the patients with SLE (42%) than in the control subjects (24%). On the contrary, Dourmishev et al. [8] showed that the TNF-a À308 polymorphism was not associated with increased risk for Bulgaria patients with SLE. This inconsistency might be due to investigations with inadequate statistical power, racial and ethnic differences, publication bias, or uncorrected multiple hypothesis testing. Therefore, in this study, we carried out an additional case-control study on the relationship between TNF-a À308 A/G (rs1800629) and SLE risk in a Chinese Han population and presented a meta-analysis based on currently available data. We hope to clarify the association between TNF-a À308 A/G and SLE risk.
Materials and methods
Case-control study sample. There are 556 patients with SLE and 570 healthy controls of South Han Chinese origin recruited in this study. Patients are collected from the Sichuan Province, China. All patients met the 1997 revised American College of Rheumatology criteria for SLE [9] . Lupus nephritis (LN) was determined according to the WHO classification [10] . Of the patients, 520 were female and 36 were male [range from 16 to 71 years, median age 28.0 (27.0-33.0) years]. Healthy controls were collected from the general population, blood donors with no history of autoimmune disorders. Among the healthy controls, 514 were female and 56 were male [range from 15 to 79 years, median age 28.0 (24.0-38.3) years]. Data about demographic and clinical features, age at diagnosis, were collected from hospital records or by questionnaire and reviewed by experienced physicians. All subjects gave their written consent to participate before study. This study was approved by the Ethics Committee of the Southwest Medical University.
Genotyping. The genomic DNA was extracted from peripheral blood leucocytes using Flexi Gene DNA kits (Qiagen, Beijing City, China for Qiagen; 2: Foster City, CA, USA for Applied Biosystems.) according to the manufacturer's instruction. Genotyping of the single-nucleotide polymorphism in the promoter region of the TNF-a gene (À308 A/G) was carried out by a TaqMan allele discrimination assay (Applied Biosystems). Primer sequences (forward primer 5 0 -AGGCAATAGGTTTTGAGGGCCAT-3 0 ; reverse primer: 5 0 -TCCTCCCTGCTCCGATTCCG-3 0 ) were used. A polymerase chain reaction (PCR) was used to identify the genotype of the TNF-a À308 A/G (rs1800629) polymorphism. Amplification was performed in a 10 ll reaction volume containing 5 l of TaqMan Genotyping master mix, 0.1 ll of TaqMan Genotyping assay mix, 0.9 ll of ultrapure water and 4 ll of genomic DNA using a 7300 real-time PCR system (ABI7300; Applied Biosystems). PCR analysis was carried out in 96-well plates on a programmable thermal cycler. The PCR cycling conditions consisted of initial denaturation at 95°C for 10 min, followed by 40 cycles at 95°C for 15 s and at 60°C for 1 min.
Statistical analysis. The prevalence of genotypes in healthy controls was examined for deviation from HardyWeinberg equilibrium by Fisher's exact test. The differences of allele and genotype frequencies between patients with SLE and health controls were compared by the chi-square test. Unconditional multivariate logistic regression analysis was used to estimate odds ratio (OR) and 95% confidence interval (CI) for the effect of rs1800629 on SLE risk. The statistical significance was defined as P (two-tailed) <0.05. Data were analysed by SPSS 10.01 software. The SPSS 10.01 (SPSS Inc., Chicago, IL, USA) was used for data analysis.
Meta-analysis. To further estimate the association between this polymorphism and the risk of SLE, a metaanalysis was performed. Relevant studies discussing the correlation between of TNF-a promoter À308 A/G polymorphism with SLE susceptibility were fully considered and carefully selected. Data were collected from the following electronic databases: PubMed, MEDLINE, Elsevier Science Direct, Chinese Biomedical Literature Database (CBM) and Chinese National Knowledge Infrastructure (CNKI) with the last report up to March 2016. References in the studies were reviewed to identify additional studies not indexed. The following keywords were used: 'systemic lupus erythematosus', 'SLE', 'tumor necrosis factor', 'TNF-a' and 'polymorphism'. The languages were limited to English and Chinese. A study was included in the current analysis if (1) it was a case-control study, (2) it was original data (independence among studies), and (3) it provided sufficient data to calculate OR. We excluded the followings: (1) studies that contained overlapping data and (2) studies in which family members had been studied because their analysis is based on linkage considerations. Data were collected by two independent investigators, where the results were compared and disagreement was resolved by discussion. The following information was collected from each study: first author's name, year of publication, racial ancestry, the number of SLE cases and controls, and the available genotype and allele frequency information from the TNF-a promoter À308 A/G polymorphism.
Allele frequencies at the TNF-a promoter À308 A/G polymorphism from the respective study were examined by the allele counting method. A chi-square test was used to discuss whether the observed genotype frequencies in the controls conformed to Hardy-Weinberg (H-W) expectations. We performed meta-analysis with fixed/random effect models using: (1) allelic contrast (A versus G), (2) the additive model (AA versus GG), (3) the recessive (AA versus AG+GG) and (4) the dominant model (AA+AG versus GG). Point estimates of risks, OR and 95% CI were examined for individual study. The within-and between-study variation or heterogeneity was assessed by the chi-square test based Qstatistic [11] . Moreover, the I 2 -statistic measures the degree of inconsistency in the studies by computing what percentage of the total variation across studies was due to heterogeneity rather than by chance [12] . A significant Qstatistic (P < 0.10) suggested heterogeneity across studies, and then, the random effects model was used. Otherwise, we used the fixed effects model for meta-analysis.
Potential publication bias was estimated via the funnel plot, in which the standard error of logOR of each study was plotted against its OR. An asymmetric plot indicates a possible publication bias. In addition, funnel plot asymmetry was examined through the Egger's linear regression test, where P < 0.05 was considered representative of statistically significant publication bias. All the statistical analyses of the present meta-analysis were performed by STATA statistical software (version 11.0 STATA Corp LP, College Station, TX, USA).
Results

Case-control study
The clinical and demographic characteristics of the included patients and the controls are presented in Table 1 . The genotype and allele distributions of rs1800629 are presented in Table 2 . The distribution of genotypes in healthy controls was not deviated from Hardy-Weinberg equilibrium (P = 0.19). The distribution of rs1800629 A allele was significantly increased in patients with SLE compared with controls (OR = 2.184, 95% CI: 1.718-2.778, P < 0.001). Similarly, genotypes AA and AG were associated with the susceptibility to SLE as compared with the GG genotype, respectively (AA versus GG, OR = 3.961, 95% CI: 1.753-8.949, P = 0.001; AG versus GG, OR = 1.701, 95% CI: 1.100-2.629, P = 0.017). We also found statistical significance in the dominant model (AA+AG versus GG, OR = 2.055, 95% CI: 1.554-2.718, P < 0.001) ( Table 2) .
In this study, 126 patients with SLE (22.7%) accompanied with LN, and therefore, we discussed allele and genotype frequencies between SLE patients with and without LN. Results showed that there were no significant differences in allele and genotype frequencies in this SNP of TNF-a gene between SLE patients with and without LN ( Table 3 ). In addition, there are eight other clinical features involved in this study, and we also discussed the possible correlation between the gene polymorphism with clinical features in patients with SLE. We observed that frequency of allele A was 6.8% and 14.6% in patients with photosensitivity and vasculitis compared with patients without these phenotypes, respectively, suggesting that patients carrying the A allele showed a trend of reduced association with photosensitivity and vasculitis (P c = 0.062, P c = 0.071). Other clinical manifestations were similar in both groups (Table 3) .
Meta-analysis
Study characteristics
The process for selecting the studies was shown in Fig. 1 . One hundred and sixty papers were relevant to the searching words, and a total of 38 studies met the inclusion criteria. Finally, there were 39 studies included in this meta-analysis including our case-control study [7, 8, . Among these recruited investigations, five were published in Chinese [29, 34, 37, 39, 40] and the others were reported in English. Two of the eligible studies contained data on two different groups [19, 31] , and these were treated independently. Collectively, a total of 41 separate comparisons were considered in the meta-analysis involving 4799 patients and 6635 controls. Seventeen studies involved European populations, fifteen studies involved Asian populations, four investigations involved South American populations, three studies implicated African populations and two studies involved North American populations, respectively. Although the allele frequency of the TNF-a promoter À308 A/G polymorphism was extracted from 41 comparisons, the genotype frequency was available from 31 comparisons. Thus, the meta-analysis was performed with 41 comparisons overall and 31 when divided for genotype-based analysis. We also calculated the distribution of genotype for H-W equilibrium in control group if available. Characteristics of studies 
SLE, systemic lupus erythematosus; LN, lupus nephritis.
Ó 2016 The Foundation for the Scandinavian Journal of Immunology discussing the correlation between TNF-a À308 A/G polymorphism with SLE were presented in Table 4 .
Meta-analysis of the association between the TNF-a À308 A/G polymorphism and SLE
An association between SLE and allele A was found in the overall populations (OR = 1.70, 95% CI: 1.46-1.98, P < 0.001, Table 5 , Fig. 2 ). Similarly, stratification by ethnicity indicates that the allele A is significantly related to SLE in Europeans (OR = 1.80, 95% CI: 1.43-2.28, P < 0.001, Table 5 , Fig. 3 ), Asians (OR = 1.47, 95% CI: 1.11-1.94, P = 0.007), South Americans (OR = 1.93, 95% CI: 1.39-2.67, P < 0.001) and North Americans (OR = 2.41, 95% CI: 1.52-3.82, P < 0.001), respectively. Conversely, there was no association detected for the Table 2 Distribution of allele and genotype frequencies of TNF-a À308 A/G polymorphism in patients with SLE and controls. Meta-analysis of the association between the TNF-a À308 A/G polymorphism and LN susceptibility
In the current meta-analysis, a total of eight comparisons including our study involving 522 patients with LN and 1947 controls were included to examine the correlation between TNF-a À308 A/G polymorphism and LN susceptibility [14, 15, 18, 20, 32, 42, 45] . Among these studies, four involved Asians, two involved Europeans, one involved South Americans and Africans, respectively. Results showed that allele A was significantly related to LN in the overall populations (OR = 1.80, 95% CI: 1.21-2.68, P = 0.004, Table 6 ). Similarly, stratification by ethnicity indicates that the allele A is significantly related to LN in Europeans (OR = 2.88, 95% CI = 1.04-7.96, P = 0.042, Table 6 ). Meta-analysis also showed a significant association between LN and the AA genotype (additive model) in overall populations (OR = 3.11, 95% CI: 1.82-5.34, P < 0.001), Europeans (OR = 3.53, 95% CI: 1.47-7.64, P = 0.004) and Asians (OR = 2.97, 95% CI: 1.42-6.22, P = 0.004), respectively (Table 6 ). In addition, we found significant associations between the recessive model and LN in overall populations (OR = 2.59, 95% CI: 1.52-4.42, P < 0.002), Europeans (OR = 2.47, 95% CI: 1.10-5.53, P = 0.028) and Asians (OR = 2.70, 95% CI: 1.30-5.62, P = 0.008), respectively (Table 6 ). With respect to the dominant model, we detected a significant association with LN in overall populations (OR = 1.89, 95% CI: 1.51-2.38, P < 0.001), Asians (OR = 1.69, 95% CI: 1.21-2.34, P = 0.002) and Europeans (OR = 2.48, 95% CI: 1.69-3.65, P < 0.001) ( Table 6 ). Because of not enough samples to genotype frequency calculation, stratified analysis based on ethnicityspecific for South Americans and Africans was not carried out.
Meta-analysis of the association between the TNF-a À308 A/G polymorphism and photosensitivity, vasculitis
As we have found a reduced frequency of A allele in patients with photosensitivity and vasculitis, some other studies that discussed the associations of A allele, genotypes, and photosensitivity and vasculitis are inconsistent. In this meta-analysis, a total of seven studies including our study involving 458 SLE patients with photosensitivity and 870 SLE patients without photosensitivity were included to examine the correlation between TNF-a À308 A/G polymorphism and photosensitivity [14, 16, 17, 20, 38, 45] . Of these studies, we are able to extract the information about the frequencies of alleles A and G and genotypes AA, AG and GG from four studies including our study [14, 20, 45] , while the other three studies give information about the frequencies of AA+AG and GG only. Consequently, comparisons between allelic contrast (A versus G), the additive model (AA versus AG) and the recessive model (AA versus AG+GG) were carried out in the four studies, respectively, and the comparison between dominant models (AA+AG versus GG) was carried out in the seven studies. We found that neither the allelic contrast nor the genotypes comparisons showed significant differences overall (P > 0.05) ( Table 7) . Similarly, stratification by ethnicity indicated that the dominant model was not significantly related to patients with photosensitivity in Europeans. In addition, there is little information about the association of TNF-a À308 A/G polymorphism and SLE patients with vasculitis [42] , where Sullivan et al. found that vasculitis appeared to occur similarly in SLE patients with the TNF-a À308 G allele compared with those with the TNF-a À308 A polymorphism. Therefore, we cannot do a meta-analysis to discuss the association of TNF-a À308 A/G polymorphism with SLE patients with vasculitis because of not enough samples.
Evaluation of publication bias
Egger's linear regression test was used to examine the asymmetry of the funnel plot. If there was asymmetry, with smaller studies showing effects that differ systematically from larger studies, the regression line will not run through the origin. The intercept a provides a measure of asymmetry -the larger its deviation from zero, the more pronounced the asymmetry. The results of Egger's linear regression test were displayed in Table 5 . Results showed that there was no publication bias in all comparisons, but due to the small number of studies in one comparison (North American: A versus G), Egger's test was not applied. For example, when discussed the association between SLE and A allele (A versus G) in overall populations, the Egger's linear regression test provided no evidence of publication bias, and the distribution of the ORs from individual studies in relation to their respective standard deviation was symmetric in funnel plots (t = À0.48, P = 0.632) (Fig. 5A) . Similarly, the Egger's linear regression test and funnel plot for publication bias on allelic contrast (A versus G) in Europeans and the dominant model (AA+AG versus GG) in overall populations also showed no publication bias, respectively (t = À0.03, P = 0.977; t = À0.94, P = 0.355) (Fig. 5B , C).
Discussion
Systemic lupus erythematosus is a multifactorial disease with numerous immunological and clinical manifestations, as well as heterogeneity of underlying mechanisms, which can affect multiple organs. It has been widely accepted that there is individual susceptibility to autoimmune diseases including SLE even with identical environmental exposure. Host factors, including polymorphisms of genes implicated in SLE, might have accounted for this difference among individuals at least to some degree. Therefore, genetic vulnerability to SLE has been a topic of intensive research in scientific community [49] . It has been postulated that genetic polymorphisms affecting cytokine transcription exist in the regulatory regions of proinflammatory cytokine genes and that such polymorphisms may regulate the level of inflammation. Several SNPs (À238, À308, À857, À863) within the promoter region of the TNF-a gene have been discussed, and some of them are related to altered levels of circulating TNF and may influence in susceptibility and severity of diseases, might be functional and prove useful for disease association studies. Among them, the best-described polymorphism is located at nucleotide position À308 that modifies the consensus sequence for a binding site of the transcription factor AP-2 [50] . TNF-a stimulates the generation of inflammatory cytokines, promotes neutrophil activation and expression of adhesion molecules and performs as a costimulator for T cell activation and antibody production. Accordingly, in vivo and in vitro studies confirmed that TNF-a exhibits effects that control autoimmunity and high levels of TNF-a results in exacerbation of the inflammatory response [50] . Therefore, overproduction of TNF-a might play a role in susceptibility to the development of autoimmunity. Abnormal TNF-a production is involved in several autoimmune diseases, such as SLE, rheumatoid arthritis, psoriasis and ankylosing spondylitis [51, 52] . The role of aberrant TNFa signalling in the development of lupus was also suggested by the contribution of tumour necrosis factor receptor II functional genetic variants to SLE [53] [54] [55] [56] . Therefore, genetic variants of TNF-a may have an effect on the susceptibility to SLE development, as well as on its clinical manifestations. Recently, genetic variants of the TNF-a À308A/G polymorphism in the aetiology of several autoimmune Overall (I-squared = 71.9%, P = 0.000) Rudwaleit (2009) Suaez (2005) Goldstein (1993) Liu (2001) Correa (2005) Chen (1997) Piotrowski (2015) Jimenez-Morales (2009) Munoz (2014) Azizah (2004) Zuniga (2001) Lu (2005) Angelo (2012) Danis (1994) Ahmed (2014) Parks (2004) Wilson (1994) Dourmishev (2012) Rudwaleit (2009) Parks (2004) Linden (2001) Fugger (1989) Fu ( Tsai (2008) Lin (2009) McHugh (2006) Schotte (2005) Yang (2016) Lin (2010) 204 TNF-a Polymorphism Lupus diseases have drawn increasing attention. The frequency of the A allele in TNF-a À308 polymorphism from RA sufferers was not significantly higher than in the controls in the Brazilian [57] . By contrast, the frequency of the risk A allele, as well as the distribution of AG and AA genotypes, was significantly higher in Croatian patients with type 1 diabetes at locus À308 when compared with controls [58] .
In the context of this polymorphism and SLE/LN, the results are inconclusive. Munoz et al. [15] reported no significant differences in the genotype distributions or allele frequencies of the TNF-a À308 A/G polymorphism between patients with SLE and controls. Similarly, there was no association between the presence of any allele or genotype and the development of LN in patients with SLE. However, there were significant differences in the distribution of the TNF-a À308 A/G gene polymorphism between the SLE and control groups in Brazilian, by which individual carriers of the variant allele A had a 3.29-fold increased risk for SLE [16] . To better understand the association between this polymorphism and SLE/LN risk, a pooled analysis with a large sample, subgroup analysis performed, and heterogeneity explored is needed. The present case-control study showed that rs1800629 A allele was significantly increased in patients with SLE (20.1%) compared with controls (10.4%), and genotypes AA and AG were associated with the susceptibility to SLE as well. Given that 69% of patients with SLE did not express the polymorphism (AA+AG), these findings indicated that the TNF-a (rs1800629) SNP appears to confer genetic predisposition to SLE risk in this Chinese Han population, and the TNF polymorphism may partly explain SLE. Patients carrying A allele showed a reduced trend of susceptibility to photosensitivity and vasculitis. Interestingly, Lin et al. [20] reported that the allele and genotype frequencies of the polymorphism at À308 were not significantly different in Taiwanese patients with SLE and controls. However, the frequency of A allele of the polymorphism at À308 was significantly increased in SLE patients with photosensitivity (56.3%) when compared with the patients without this phenotype. Moreover, Overall (I-squared = 75.8%, P = 0.000) D'Alfonso (1996) Linden (2001) Fugger (1989) Danis (1994) McHugh (2006) Goldstein (1993) Rudwaleit (2009) Schotte (2005) Dourmishev (2012) Hrycek (2005) Rood (2000) ID May (2002) Santos (2012) Wilson (1994) Parks (2004) Suaez (2005) Piotrowski (2015 Piotrowski et al. [14] found no significant differences of the genotypes between patients with photosensitivity and the non-photosensitivity patients. Similarly, Sullivan et al.
showed that frequency of A allele was similar between vasculitis patients and non-vasculitis patients. To further investigate the association of polymorphism and photosensitivity and vasculitis in this study, we did a metaanalysis. Result showed no significant association of this polymorphism and vasculitis neither in allelic comparison nor in genotype comparisons, suggesting that this polymorphism may not correlate with photosensitivity. Owing to limited studies about the polymorphism and vasculitis, we cannot conclude that whether this polymorphism was related to vasculitis.
The present meta-analysis showed that the allele A was associated with SLE risk in overall populations. Similarly, the genotype AA was related to SLE risk in overall populations not only in the additive model and the recessive model, but also in the dominant model. Ethnicity-specific analysis showed that the allele A in the TNF-a À308 gene might confer susceptibility to SLE in Europeans, Asians, South Americans and North Americans. Subgroups analysis also indicated that the additive model and the recessive model were related to Europeans, Asians and South Americans and the dominant model correlated with the Europeans and South Americans, respectively. Compared with the previous meta-analysis [59] , Pan et al. contained 30 comparative studies, including 14 Europeans, Overall (I-squared = 68.4%, P = 0.000) Wang (1998) May (2002) Zuniga (2001) Munoz (2014) Yang (2016) Tahghighi (2015) Ahmed (2014) Suaez (2005) Goldstein (1993) Parks (2004) Fong (1996) Guarnizo-Zuccardi (2007) Lin ( Schotte (2005) Santos (2012) Parks (2004) Wilson (1994) Lu (2005) Hrycek (2005) Danis (1994) Fugger (1989) Lin (2010) Rood (2000) Angelo (2012) Dourmishev (2012) Wang (1999) Hirankarn (2007) Piotrowski (2015) Tsai (2008 Firstly, we additionally found that allele A, the additive model and the recessive model were significantly related to SLE susceptibility in Asians. Similarly, the recessive model was significantly related to the South Americans. Secondly, as LN is one of the most common manifestations in SLE and remains a predominant cause of morbidity and mortality in SLE, it is necessary to discuss the relationship between TNF-a À308 polymorphism and LN susceptibility. In our study, results indicated that the TNF-a À308 polymorphism was related to LN disease risk in overall populations not only in allelic comparison, but also in the additive model, the recessive model and the dominant model. Ethnicity-based analysis also showed that the TNFa À308 polymorphism was related to LN in Europeans in all comparisons and in Asians in the additive, recessive and dominant models. Thus, it is possible that TNF-a À308 polymorphism may confer susceptibility to LN. Some limitations of the present study should be considered. Firstly, the TNF gene cluster is found within the MHC class III region, about 850 kb telomeric of the HLA-DRB1 locus, and several studies showed that HLA-DRB1 and TNF polymorphisms are associated with the susceptibility to SLE [19, 25, 28, 38] . However, because of linkage disequilibrium between HLA-DR3 and TNF-a À308 A/G, it is currently not clear whether the association with SLE reflects independent gene effects. DR3 is not associated with SLE in African-Americans and is not known to be in linkage disequilibrium with TNF-a À308A in West Africans [60] . Sullivan, et al. [42] showed that the gene frequency of TNF-a À308A allele was higher in the African-American SLE population than in the control population, and the frequency of the A allele in patients with SLE who did not bear DR3 was significantly higher compared with the frequency in the control population (OR = 4.44, 95% CI: 1.50-13.3, P = 0.0052), suggesting that the association of TNF-a À308A with SLE in African-Americans cannot be attributed to its association with DR3. Similarly, in a study of Netherland Caucasian patients with SLE, Rood et al. [38] found that the frequencies of the TNF-a À308 AA and AG genotypes were significantly higher in patients with SLE. The HLA-DR3 specificity (DRB1*0301 allele) was significantly more prevalent in the SLE population as well. However, stratification to correct for interdependence of the loci demonstrated the association of both TNF-a À308A and HLA-DR3 with SLE, respectively, and no correlation was noted between TNF-a promoter and HLA-DRB1 genotypes and any disease manifestations. Furthermore, Schotte et al. [28] revealed both higher frequencies of alleles DR3 and TNF-a À308A in German Caucasian patients with SLE, and positive correlation between allele A and HLA-DR3, whereas in haplotypes lacking DR3, the allele A contributed independently to SLE susceptibility. On the contrary, Rudwaleit et al. [19] reported that the frequency of A allele was strongly upregulated in the United Kingdom Caucasian patients with SLE compared to controls, and there was an increase in the frequency of HLA-DR3 in patients with SLE. Among these patients, allele A was strongly related to the presence of DR3, by which allele A was present in 89.0% of DR3-positive patients, and only 26.0% allele A-positive patients were not DR3, indicating that the increase of allele A in patients with SLE is most likely due to linkage disequilibrium between TNF-a À308A and HLA-DR3. Therefore, it is important to further discuss the relationship of TNF-a À308 A/G and HLA-DR3 in SLE although the present study has not carried out because of some impossibilities. Secondly, we could not analyse the potential gene-environment interactions owing to lack of data, such as the data of environmental risk factors and genotypes. Thirdly, meta-analysis remains a retrospective research, which is subject to the methodological deficiencies of the included studies. In summary, this case-control study adds to the growing evidence of the effect of rs1800629 on SLE risk and the meta-analysis verified a significant association between rs1800629 A allele and SLE risk.
